SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001969223-24-000011
Filing Date
2024-01-19
Accepted
2024-01-19 15:26:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2808
  Complete submission text file 0001969223-24-000011.txt   4251
Mailing Address 1301 SECOND AVE., SUITE 4200 SEATTLE WA 98101
Business Address
LASEZKAY GEORGE M (Reporting) CIK: 0001020514 (see all company filings)

Type: 144

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Subject) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37783 | Film No.: 24545391
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)